Literature DB >> 9518978

The influence of program acceptability on the effectiveness of public health policy: a study of directly observed therapy for tuberculosis.

S J Heymann1, R Sell, T F Brewer.   

Abstract

OBJECTIVES: This study examined how patient acceptability influences the effectiveness of directly observed therapy for tuberculosis.
METHODS: Decision and sensitivity analyses were used in assessing influences.
RESULTS: If mandatory directly observed therapy discourages 6% of initial tuberculosis patients (range: 4% to 10%) from seeking care, then such therapy will be less effective than self-administered therapy. Directly observed therapy is more effective than repeated self-administered therapy for patients failing to complete initial treatment unless 32% (range: 27% to 38%) of patients avoid seeking care.
CONCLUSIONS: Patient acceptability must be taken into consideration before selecting public health strategies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9518978      PMCID: PMC1508357          DOI: 10.2105/ajph.88.3.442

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  15 in total

1.  Eleven years of community-based directly observed therapy for tuberculosis.

Authors:  C P Chaulk; K Moore-Rice; R Rizzo; R E Chaisson
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

2.  Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli.

Authors:  M A Fischl; G L Daikos; R B Uttamchandani; R B Poblete; J N Moreno; R R Reyes; A M Boota; L M Thompson; T J Cleary; S A Oldham
Journal:  Ann Intern Med       Date:  1992-08-01       Impact factor: 25.391

3.  USPHS Tuberculosis Short-Course Chemotherapy Trial 21: effectiveness, toxicity, and acceptability. The report of final results.

Authors:  D L Combs; R J O'Brien; L J Geiter
Journal:  Ann Intern Med       Date:  1990-03-15       Impact factor: 25.391

4.  Short-course chemotherapy for tuberculosis with mainly twice-weekly isoniazid and rifampin. Community physicians' seven-year experience with mainly outpatients.

Authors:  A K Dutt; D Moers; W W Stead
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

5.  Predictors and outcome of multidrug-resistant tuberculosis.

Authors:  N Salomon; D C Perlman; P Friedmann; S Buchstein; B N Kreiswirth; D Mildvan
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

6.  The emergence of drug-resistant tuberculosis in New York City.

Authors:  T R Frieden; T Sterling; A Pablos-Mendez; J O Kilburn; G M Cauthen; S W Dooley
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

7.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection.

Authors:  P M Small; G F Schecter; P C Goodman; M A Sande; R E Chaisson; P C Hopewell
Journal:  N Engl J Med       Date:  1991-01-31       Impact factor: 91.245

8.  Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.

Authors:  M Goble; M D Iseman; L A Madsen; D Waite; L Ackerson; C R Horsburgh
Journal:  N Engl J Med       Date:  1993-02-25       Impact factor: 91.245

Review 9.  Epidemiology of tuberculosis in the United States.

Authors:  H L Rieder; G M Cauthen; G W Comstock; D E Snider
Journal:  Epidemiol Rev       Date:  1989       Impact factor: 6.222

10.  Tuberculosis, poverty, and "compliance": lessons from rural Haiti.

Authors:  P Farmer; S Robin; S L Ramilus; J Y Kim
Journal:  Semin Respir Infect       Date:  1991-12
View more
  5 in total

1.  Does directly observed therapy work?

Authors:  W J Burman; W el-Sadr
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

2.  Directly observed therapy for tuberculosis.

Authors:  S Marks; C Nguyen; N Qualls; Z Taylor
Journal:  Am J Public Health       Date:  1999-04       Impact factor: 9.308

Review 3.  Lipoarabinomannan and related glycoconjugates: structure, biogenesis and role in Mycobacterium tuberculosis physiology and host-pathogen interaction.

Authors:  Arun K Mishra; Nicole N Driessen; Ben J Appelmelk; Gurdyal S Besra
Journal:  FEMS Microbiol Rev       Date:  2011-05-31       Impact factor: 16.408

4.  Treatment completion among TB patients returned to the community from a large urban jail.

Authors:  Seijeoung Kim; Kathleen Crittenden
Journal:  J Community Health       Date:  2007-04

5.  Patient support for tuberculosis patients in low-incidence countries: A systematic review.

Authors:  Sarah van de Berg; Niesje Jansen-Aaldring; Gerard de Vries; Susan van den Hof
Journal:  PLoS One       Date:  2018-10-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.